Skip to content

AYURVEDIC MANAGEMENT FOR ENDOMETRIOSIS

EFFICACY OF VIRECHANA, DASHAMOOLA KSHEERA BASTI ALONG WITH PANCHATIKTAGHRUTA GUGGULU AND GANDHARVAHASTADI KASHAYA ORALLY IN THE MANAGEMENT OF ENDOMETRIOSIS- A SINGLE ARM OPEN LABELLED CLINICAL TRIAL

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/05/042739
Enrollment
15
Registered
2022-05-23
Start date
Unknown
Completion date
Unknown
Last updated
2022-05-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N801- Endometriosis of ovary

Interventions

Intervention1: Medicine: 3. Panchtiktaghrita Guggulu: 2 tablet (each of 500 mg)TDS with hot water administrate by oral route before meal for 2 months. 4. Gandharvahastadi Kashaya: 50 ml BD with anupan

Sponsors

Institute of Teaching and Research in Ayurveda Jamnagar
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.patients either asymptomatic or having clinical signs and symptoms of endometriosis 2.patients eligible for Virechana karma and Basti karma 3.patients having CA-125 level 4.women with Hb >7 gm%

Exclusion criteria

Exclusion criteria: 1.patient having chocolate cyst size greater than or equal to 7 cm as per USG report 2.pregnant women with endometriosis 3.women with Hb 4.suspected carcinoma of reproductive tract 5.patient with infectious diseases of reproductive tract like tuberculosis, sexually transmitted diseases 6.congenital anomaly of reproductive tract 7.patients with history of cardiac diseases, chronic liver disease, uncontrolled hypertension (systolic BP above 160 & Diastolic above 100 mmHg), uncontrolled diabetes mellitus (above the range of 160 mg/dl-RBS) 8.patients not eligible for Virechana karma and Basti 9.patients having CA_125 level >500 U/ML

Design outcomes

Primary

MeasureTime frame
Reduction in the size of endometriosis by using USG findings according to American Society for Reproductive Medicine Revised Classification of Endometriosis & Changes in Value of CA-125 and reduction in Dysmenorrhoea, Dyspareunia and deep seated pelvic pain by using VAS score and Scale.Timepoint: B.T.(0 day) and A.T.(After 3 months)

Secondary

MeasureTime frame
Improvement in cardinal and associated clinical features related to endometriosis i.e.menorrhagia, premenstrual bleeding and intermenstrual bleeding,vomiting,dyschezia, dysuria.Timepoint: B.T.(0 day) and A.T.(after 3 months)

Countries

India

Contacts

Public ContactProf shilpa B Donga

Institute of Teaching and Research in Ayurveda

drshilpadonga@yahoo.com9825646796

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026